Overview

Update
Total Equity Funding
$14.05M in 5 Rounds from 6 Investors
Most Recent Funding
$5M Series B on March 21, 2016
Headquarters:
St Louis, MO
Description:
Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.
Categories:
Biotechnology, Health Diagnostics, Clinical Trials
Website:
http://www.adarzabio.com

Company Details

Update

Adarza BioSystems is an early stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology is fully arrayable, potentially allowing hundreds of tests to be run simultaneously on a single chip.

Funding Rounds (5) - $14.05M

Update
DateAmount / RoundValuationLead InvestorInvestors
Mar, 2016$5M / Series B3
Oct, 2014$6.8M / Series A2
Jul, 2014$2M / Series A2
Jul, 2013$250k / Seed0
Apr, 2013undisclosed amount / Seed2

Current Team (5)

Update

Offices/Locations (2)

Update
  • Office

    150 Lucius Gordon Dr., Suite 100

    West Henrietta, NY 14586

    USA

  • Office

    4041 Forest Park Ave.

    St Louis, MO 63108

    USA

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos